Monopar Therapeutics
Manufacturing · Illinois, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1000 Skokie Blvd Ste 350, Wilmette, Illi...Phone Number
(847) 388-0349Website
www.monopartx.comRevenue
$7.5 MillionStock Symbol
MNPRIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
1
1
1
1
About Monopar Therapeutics
Monopar Therapeutics is a biopharmaceutical company founded in 2014 that specializes in developing orphan oncology compounds for the treatment of rare cancers. The company focuses on innovative therapeutic approaches, including monoclonal antibodies that target specific cancer pathways. Monopar Therapeutics works on developing treatments for several deadly cancers through specialized pharmaceutical research and clinical trials. With operations in both San Francisco, California and Chicago, Illinois, the company collaborates with international research organizations to advance its pharmaceutical development pipeline. Monopar Therapeutics maintains a focus on addressing unmet medical needs in oncology through its specialized pharmaceutical manufacturing and development processes.Explore more
Monopar Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
JH
Director, Supply Chain Operations
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Monopar Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Monopar Therapeutics is spiking on competitors!
Check if Monopar Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Monopar Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Monopar Therapeutics
Earning: See what the market has to say on Monopar Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Monopar Therapeutics has new funding data
Product Launch: Get notified when Monopar Therapeutics launches new products
Monopar Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Monopar Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Monopar Therapeutics
Compare insights from companies similar to Monopar Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Monopar Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Monopar Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Monopar Therapeutics.
Monopar Therapeutics financials insights
Gather financial insights about Monopar Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Private Equity
$2.1M
Monopar Therapeutics Tech Stack
A closer look at the technologies used by Monopar Therapeutics
Most Recent Scoops
Project
, according to a mid-level source in operations management, is planning to begin initiatives related to environmental, quality and safety management software within three to six months. These efforts are focused on cleanroom safety, sterility, and quality.
Software, Safety, Health & Safety, Operations
Project
, according to a mid-level source in operations management, is planning to leverage AI-driven quality control and inspection support over the next six to twelve months.
Artificial Intelligence, Operations
Pain Point
, according to a mid-level source in operations management, is experiencing challenges related to approval management.
Pain Point, Records Management, Workforce Management, Operations
Project
, according to a mid-level source in operations management, is in the midst of initiatives related to digital transformation. The organization is currently evaluating Capgemini. Monopar Therapeutics will be increasing funding and is expected to increase permanent employee workforce to support these efforts.
Spending/Investment, Financial Planning, Funding, Digital Transformation, Finance, Operations
Project
Spending/Investment, Contingent Workforce, Financial Planning, Funding, Logistics / Supply Chain, Finance, Operations
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Monopar Therapeutics
Sign Up For FreeTo access detailed company insights
Monopar Therapeutics is a biopharmaceutical company founded in 2014 that specializes in developing orphan oncology compounds for the treatment of rare cancers. The company focuses on innovative therapeutic approaches, including monoclonal antibodies that target specific cancer pathways. Monopar Therapeutics works on developing treatments for severa... Read More
